Want to join the conversation?
$ANGO, a medical device company, reported net income for 3Q16 compared to a net loss in 3Q15, helped by higher net sales and gross profit. $ANGO said it posted a net income of $0.63MM, or $0.02 per share compared to a net loss of $4.26MM or $0.12 per share a year ago. Net sales rose 1% to $87.38MM. Excluding items, $ANGO earned $0.15 per share.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?